People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Health Care, Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renovia Inc. | — | Other Health Care | Series B | $57.5M | $348.3M | 2017 |
| Minerva Neurosciences, Inc. | — | Biotechnology | Series B | $52.0M | $219.4M | 2015 |
| Good Start Genetics, Inc. | — | Biotechnology | Series B | $28.2M | $396.9M | 2012 |
| Origami Surgical Inc. | — | Medical Devices | Seed | $6.8M | $1.3M | 2020 |
Marc Beer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc Beer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Tara Butler | 1 | 12 |
| Mark Levine | 1 | 9 |
| Gary Kurtzman | 1 | 8 |
| Lutz Giebel | 1 | 6 |
| Adam Stone | 1 | 5 |
| Joseph Lee | 1 | 5 |
| Robert Carpenter | 1 | 5 |
| Michele Ollier | 1 | 4 |
| Francesco De Rubertis | 1 | 4 |
| Eileen Maus | 1 | 3 |
| Jim O'Connor | 1 | 3 |
| Robert J. Carpenter | 1 | 3 |
| Remy Luthringer | 1 | 2 |
| John Fallon | 1 | 2 |
| Jan Van Heek | 1 | 2 |
| David Kupfer | 1 | 2 |
| Scott Flora | 1 | 2 |
| Don Hardison | 1 | 2 |
| CARL J. GORDON | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.